Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Adjuvant Electromotive Mitomycin-C in Patients With pTa-pT1 and G1-G2 Non-muscle Invasive Bladder Cancer: a Randomized Controlled Trial

NCT01920269 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT01920269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01920269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Adjuvant Electromotive Mitomycin-C in Patients With pTa-pT1 and G1-G2 Non-muscle Invasive Bladder Cancer: a Randomized Controlled Trial
Lead sponsor
University of Rome Tor Vergata
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 1994
Completion date
June 30, 2013
Enrollment
331 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer tnm staging primary tumor (t) t1, bladder cancer tnm staging primary tumor (t) ta, bladder cancer transitional cell grade